[Discussion] we are measuring handling at the wrong time and calling it noise
The title is the argument: we are measuring handling at the wrong time and calling it noise. Here is the rest of it.
For any compound with a thin testing history, identity is the first question. Mass spectrometry against a theoretical mass answers it; an area-percent purity figure does not.
On the thin testing history in this board, and what to do about it.
Most of the compounds discussed here have a handful of independent results across the entire site, and several have none. That is a fact about how few members have paid for testing, not a judgement about the material.
What follows: buy small, test identity first for anything unusual, and post the result even when it is unremarkable. The vendor source pages are built from exactly these submissions, and the compounds with the thinnest coverage are the ones where one more entry changes the picture most. Research material is not approved for human use, so what this board can usefully build is an analytical record.
Why purity and net content diverge, and why that is usually honest.
Purity by area percent is a relative measure of what the detector saw. Net peptide content subtracts counterion, water and residual solvent from the powder mass. For some compounds in this catalogue the gap between the two is large.
A vial can therefore be 99% pure and contain considerably less peptide by mass than the label weight suggests, with nothing wrong anywhere. The problem is not the chemistry; it is that people compare a purity figure from one supplier with a net content figure from another and conclude something about both. Ask which number you are being shown, every time.
If somebody has the same thing measured a different way, post it next to mine and we will see whether they agree.
best — the order this archive was captured in
Research-use-only material is not approved for human use. In this catalogue that covers essentially everything, which is why the board discusses material and analytics rather than outcomes.
Stocked lines and made-to-order lines have different lead times and different storage histories. Both are ordinary; the difference is worth confirming before you commit.
Push back: handling advice from one compound does not transfer to another just because both are peptides.
Push back: handling advice from one compound does not transfer to another just because both are peptides.
Adding the practical question — stocked or made to order, and what is the lead time.
Adding the practical question — stocked or made to order, and what is the lead time.
Disagreeing with this bit: handling for one compound does not transfer to another by default.
purity methods differ between compound classes
handling and storage vary enormously across this catalogue
research-use-only material is not approved for human use
the less-tested the compound, the more the identity test matters
handling and storage vary enormously across this catalogue
Agreed — and the naming problem is worse than most people here realise.